MONDAY, June 24, 2024 -- For patients with acute myeloid leukemia (AML) undergoing allogeneic stem cell transplantation, posttransplant...

Investors need to pay close attention to Biogen (BIIB) stock based on the movements in the options market lately.

Amgen (AMGN) closed at $319.31 in the latest trading session, marking a +0.36% move from the prior day.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

DelveInsight’s, “Advanced Merkel cell carcinoma Pipeline Insight 2024” report provides comprehensive insights...

Driven by pipeline approvals with diverse mechanisms of action and an influx of newly diagnosed patients, the chronic kidney disease (CKD) market is...

The chronic kidney disease market is forecast to grow at a 19.6% CAGR from (Dollar) 2.2 billion in 2023 to (Dollar) 13.5 billion by 2033 across...

Nigerian undergraduates can now apply for the 2024 Helix Biogen

Newmont Corporation (NEM) closed the most recent trading day at $42.60, moving +0.8% from the previous trading session.

Newmont Corporation (NEM) closed the most recent trading day at $41.90, moving -1.64% from the previous trading session.